Non-Escherichia coli versus Escherichia coli community-acquired urinary tract infections in children hospitalized in a tertiary center: Relative frequency, risk factors, antimicrobial resistance and outcome

Pediatric Infectious Disease Journal

Volumn 24, Issue 7, 2005, Pages 581-585

  Marcus, Nir ^a   Ashkenazi, Shai ^a,c   Yaari, Arnon ^a,c   Samra, Zmira ^b,c   Livni, Gilat ^a,c  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Antibiotic resistance; Children; Escherichia coli; Urinary tract infections; Uropathogens

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOPENICILLIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFALEXIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; GENTAMICIN; MONOBACTAM; NALIDIXIC ACID; NITROFURANTOIN; OFLOXACIN; PIPERACILLIN; QUINOLONE DERIVATIVE; UREIDOPENICILLIN; VANCOMYCIN;

AGE DISTRIBUTION; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; CHILD; CHILD HOSPITALIZATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; COLONY FORMING UNIT; CONTROLLED STUDY; ENTEROBACTER INFECTION; ESCHERICHIA COLI; FEMALE; HUMAN; INFANT; KIDNEY DISEASE; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; PROTEUS; PSEUDOMONAS AERUGINOSA; RISK FACTOR; TREATMENT OUTCOME; URINARY TRACT INFECTION; URINE CULTURE;

EID: 22244449679     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000168743.57286.13     Document Type: Article

References (22)

1. Schlager TA. Urinary tract infections in infants and children. Infect Dis Clin North Am. 2003; 17:353-365.
2. Elder JS. Urologic disorders in infants and children. In: Behrman RE, Klicgman RM, Jenson HB, eds. Nelson Textbook of Pediatrics. 17th ed. Philadelphia, PA: W. B. Saunders; 2004:1785-1790.
3. Hoberman A, Han-Pu C, Keller DM, et al. Prevalence of urinary tract infection in febrile infants. J Pediatr. 1993;123:17-23.
4. Craig JC, Irwig LM, Knight JF, et al. Symptomatic urinary tract infection in preschool Australian children. J Paediatr Child Health. 1998;34:154-159.
5. Ashkenazi S, Even-Tov S, Samra Z, et al. Uropathogens of various childhood populations and their antibiotic susceptibility. Pediatr Infect Dis J. 1991;10:742-746.
6. Hellerstein S. Urinary tract infections: old and new concepts. Pediatr Clin North Am. 1996;42:1433-1457.
7. Hoberman A, Wald ER, Kickey RW, et al. Oral versus initial intravenous therapy for urinary tract infections in young febrile children. Pediatrics. 1999;104:79-86.
8. Welch TR, Forbes TA, Drummond KN, et al. Recurrent urinary tract infection in girls: group with lower tract findings and a benign course. Arch Dis Child. 1976;51:114-119.
9. Winter AL, Hardy BE, Alton DJ, et al. Acquired renal scars in children. J Urol. 1983;129:1190-1194.
10. Committee on Quality Improvement. Subcommittee on Urinary Tract Infections. Practice parameter: the diagnosis, treatment, and evaluation of the initial UT1 in febrile infants and young children. Pediatrics. 1999;103:843-852.
11. Bagga A, Babu K, Kanitkar M, Srivastava RN. Consensus statement on management of urinary tract infections. Indian Pediatr. 2001;38:1106-1115.
12. Gupta K. Emerging antibiotic resistance in urinary tract pathogens. Infect Dis Clin North Am. 2003;17:243-259.
13. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Fourth Informational Supplement. NCCLS Document M7-A3. Villanova, PA: Clinical and Laboratory Standards Institute, 1994.
14. Prais D, Straussberg R, Avitzur Y, et al. Bacterial susceptibility to oral antibiotics in community acquired urinary tract infection. Arch Dis Child. 2003;88:215-218.
15. Ladhani S, Gransden W. Increasing antibiotic resistance among urinary tract isolates. Arch Dis Child. 2003;88:444-445.
16. Sakran W, Miron D, Halevy R, et al. Community acquired urinary tract infection among hospitalized children in northern Israel: pathogens, susceptibility patterns and urinary tract anomalies. Harefuah. 2003;142: 249-252.
17. Allen UD, MacDonald N, Fuite L, et al. Risk factors for resistance to "first-line" antimicrobials among urinary tract isolates of Escherichia coli in children. J Am Med Child. 1999;160:1436-1440.
18. Howard AJ, Magee JT, Fitzgerald KA, Dunstan FDJ. Factors associated with antibiotic resistance in coliform organisms from community urinary tract infection in Wales. J Antimicrob Chemother. 2001;47:305-313.
19. Schalager TA. Urinary tract infections in children younger than 5 years of age: epidemiology, diagnosis, treatment, outcome and prevention. Paediatr Drugs. 2001;3:219-227.
20. Santen SA, Altieri MF. Pediatric urinary tract infection. Emerg Med Clin North Am. 2001;19:675-690.
21. Wright SW, Wren KD, Haynes ML. Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates. J Gen Intern Med. 1999;14: 606-609.
22. Foxman B. Epidemilogy of urinary tract infections: incidence, morbidity and economic costs. Am J Med. 2002;8:5S-13S.